Effectiveness and safety of clinical use of stem cells and its implications for regulations
10.19428/j.cnki.sjpm.2022.21988
- VernacularTitle:干细胞临床使用有效性和安全性及其对监管的启示
- Author:
Xin LI
1
;
Dongzhe LU
1
;
Ping ZHOU
1
;
Yizhong ZHANG
1
;
Ang LI
2
;
Xiaoxi WANG
2
;
Zhaohui WU
2
;
Di XUE
1
Author Information
1. School of Public Health, Fudan University, Key Lab of Health Technology Assessment, Shanghai 200032, China
2. China Medicinal Biotechnology Association, Beijing 100022, China
- Publication Type:Review
- Keywords:
stem cell;
clinical research;
benefit;
risk;
safety
- From:
Shanghai Journal of Preventive Medicine
2022;34(11):1165-1169
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze the effectiveness and safety of clinical use of different types of stem cells to provide evidence for governmental supervision of key issues in clinical utilization of stem cells. MethodsSix literature databases in China and abroad were searched for relevant literature published from January 2010 to July 2020， and a systematic review was conducted. ResultsThe study showed 72 studies concerning the effectiveness and safety of different types of stem cells in clinical utilization. Although clinical utilization of stem cells had some therapeutic effects for certain diseases， their long-term effect and safety need to be further evaluated， especially their potential risk of tumorigenicity. ConclusionTo protect the patients’ interest， physicians should fully weigh the benefits against the risks of clinical utilization of stem cells， and relevant governmental departments should strengthen supervision of ethics of clinical research and therapies involving stem cells as well as supervision of stem cell products.
